Liquid biopsy and 18F-FDG PET/CT derived parameters as predictive factors of osimertinib treatment in advanced EGFR-mutated NSCLC
Upvotes: 1
Favorite this post:
Mark as read:
Your rating:
Add this post to a custom list 
StoryNote Upvotes: 1